Analyst Ratings For Immunomedics (NASDAQ:IMMU)
Today, Jefferies Group raised its price target on Immunomedics (NASDAQ:IMMU) to $27.00 per share.
Some recent analyst ratings include
- 7/24/2017-Cowen Reiterated Rating of Outperform.
- 5/5/2017-Wells Fargo & Co Upgrade from a “Market Perform ” rating to a ” Outperform” rating.
Recent Insider Trading Activity For Immunomedics (NASDAQ:IMMU)
Immunomedics (NASDAQ:IMMU) has insider ownership of 6.60% and institutional ownership of 76.28%.
- On 11/20/2017 Brian A Markison, Director, sold 8,390 with an average share price of $11.89 per share and the total transaction amounting to $99,757.10.
- On 11/15/2017 Behzad Aghazadeh, Insider, bought 1,325,000 with an average share price of $10.47 per share and the total transaction amounting to $13,872,750.00.
- On 11/14/2017 Venbio Select Advisor Llc, Director, bought 1,150,000 with an average share price of $10.39 per share and the total transaction amounting to $11,948,500.00.
- On 9/1/2017 David M. Goldenberg, Insider, sold 20,000 with an average share price of $12.64 per share and the total transaction amounting to $252,800.00.
- On 8/28/2017 Cynthia L. Goldenberg, Director, sold 40,000 with an average share price of $10.72 per share and the total transaction amounting to $428,800.00.
- On 8/23/2017 Cynthia L. Goldenberg, Director, sold 40,000 with an average share price of $9.24 per share and the total transaction amounting to $369,600.00.
- On 8/24/2016 Don C Stark, Director, sold 9,900 with an average share price of $2.97 per share and the total transaction amounting to $29,403.00.
Recent Trading Activity for Immunomedics (NASDAQ:IMMU)
Shares of Immunomedics closed the previous trading session at 18.64 up +0.53 2.93% with 18.25 shares trading hands.